Related Experiment Videos
[Ultrasonic disintegration of laryngeal papilloma in children]
Insights
Ultrasonic disintegration effectively treated laryngeal papillomas in 238 children, significantly reducing tracheotomy needs and relapses. This method offers a promising, less invasive approach for pediatric patients.
Area of Science:
- Otolaryngology
- Pediatric Surgery
- Medical Technology
Background:
- Laryngeal papillomas are a significant concern in pediatric patients.
- Traditional treatments may involve invasive procedures and have high recurrence rates.
Purpose of the Study:
- To evaluate the efficacy of ultrasonic disintegration for treating laryngeal papillomas in children.
- To assess the impact of this method on tracheotomy rates and disease recurrence.
Main Methods:
- Utilized a commercial apparatus, LORA-DON, for ultrasonic disintegration.
- Treated 238 pediatric patients aged 5 months to 14 years across two clinical settings.
- Monitored immediate and remote treatment effects, including tracheotomy necessity and relapse frequency.
Main Results:
- Ultrasonic disintegration demonstrated satisfactory immediate and remote effects.
- No patients required tracheotomy during the 8-year study period.
- Relapse rates decreased significantly, by two times in Moscow and four times in Rostov.
Conclusions:
- Ultrasonic disintegration is a safe and effective treatment for pediatric laryngeal papillomas.
- This technique significantly reduces the need for tracheotomy and lowers recurrence rates.
- The LORA-DON apparatus provides a valuable therapeutic option for this condition.
Abstract:
As of today, 238 children with laryngeal papillomas were treated by ultrasonic disintegration in the ENT Department of the Moscow District Research Clinical Institute and in the ENT Department of the Rostov District Clinical Hospital. The children varied from 5 months to 14 years of age. A commercial apparatus LORA-DON was used. Immediate and remote effects of ultrasonic disintegration were quite satisfactory. During the last 8 years none of the treated patients underwent tracheotomy. The number of relapses decreased two times in the Moscow clinic and four times in the Rostov clinic.